| An international board supervises and manages The GEMI Fund. It consists of members of the medical and scientific world who have a particular interest in medical and pharmaceutical gases. Their specialties include anaesthesiology, intensive care, clinical and basic physiology and pulmonology.
Harvard Medical International and the Board of Research of the Karolinska Institute are scientific partners and members of the GEMI Fund board together with representatives appointed by Linde Gas Therapeutics.
The board will make its decisions by a simple majority vote. A majority of board members will be required to attend meeting, when decisions or votes are taken. If the board is equally divided, the chairman will cast the deciding vote.
The board of the GEMI Fund will set the amount for each grant.
The decision of the board cannot be appealed. However, proposals may be resubmitted for future funding.
Members of the GEMI Fund board
Professor Warren M. Zapol
Anesthesiology
Massachussetts General Hospital
Boston, USA |  |
|  |
Professor Claes Frostell
Anesthesiology and Intensive Care
Karolinska University Hospital
Stockholm, Sweden |  |
| |
Professor Dag Linnarsson
Physiology and Pharmacology
The Karolinska Institute
Stockholm, Sweden |  |
| |
Professor David J. Pinsky
Internal Medicine
University of Michigan
Ann Arbor, USA |  |
| |
Professor Rolf Rossaint
Anaesthesiology
University Hospital Aachen
Aachen, Germany |  |
| |
Professor Ignacio Sanchez
School of Medicine, Pediatrics
Universidad Cátolica de Chile
Santiago, Chile |  |
| |
Professor Jörg Weimann
Anaesthesiology VU University Medical Centrum
Amsterdam, The Netherlands |  |
| |
Rolf Petersen
Director, Medical Scientific Relations
Linde Gas Therapeutics
Lidingo, Sweden |  |
|
